Nestle invests $65M in Seres' D round

Microbiome company Seres Health Inc. (Cambridge, Mass.) closed a $65 million series D round from

Read the full 154 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE